UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 18, 2018
Accession Number:
0001193125-18-265133
Submission Type:
POS AM
CIK:
0001422142
Company Name:
Aerpio Pharmaceuticals, Inc.
File Number:
333-217320